TetraScience accelerates scientific AI adoption in biopharma

TetraScience collaborated with Microsoft to enable pharmaceutical organizations to extract greater value from their scientific data by leveraging enterprise AI. The partnership involved integrating TetraScience’s Scientific Data and AI Cloud with the Microsoft Azure platform, providing secure, scalable infrastructure and advanced AI capabilities to biopharmaceutical customers. The solution harmonizes scientific data across siloed and heterogeneous sources, replatforming the data into AI-ready formats and enabling multimodal analytics and fast AI model training. This empowers scientists to accelerate the entire drug discovery and development lifecycle, reducing phenotype screening times and increasing efficiency in quality control and manufacturing. Biopharma organizations reported accelerated drug safety assessment, faster phenotype screening in oncology research, and automated anomaly detection applied to manufacturing and quality control processes. Microsoft Azure supplies the computational backbone and enterprise security, while TetraScience’s platform delivers context-aware scientific data unification and automation. The collaboration is set to transform biopharma by enabling more AI-driven scientific use cases and making sophisticated analytics accessible to research organizations of all sizes.